145 related articles for article (PubMed ID: 35871647)
1. Quantitative texture analysis based on dynamic contrast enhanced MRI for differential diagnosis between primary thymic lymphoma from thymic carcinoma.
Zhu JJ; Shen J; Zhang W; Wang F; Yuan M; Xu H; Yu TF
Sci Rep; 2022 Jul; 12(1):12629. PubMed ID: 35871647
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of using dynamic contrast-enhanced MRI for differentiating thymic carcinoma from thymic lymphoma based on semi-quantitative and quantitative models.
Shen J; Xue L; Zhong Y; Wu YL; Zhang W; Yu TF
Clin Radiol; 2020 Jul; 75(7):560.e19-560.e25. PubMed ID: 32197918
[TBL] [Abstract][Full Text] [Related]
3. Whole-lesion histogram and texture analyses of breast lesions on inline quantitative DCE mapping with CAIPIRINHA-Dixon-TWIST-VIBE.
Sun K; Zhu H; Chai W; Zhan Y; Nickel D; Grimm R; Fu C; Yan F
Eur Radiol; 2020 Jan; 30(1):57-65. PubMed ID: 31372782
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of central lymphoma and high-grade glioma: dynamic contrast-enhanced histogram.
Zhang HW; Lyu GW; He WJ; Lei Y; Lin F; Feng YN; Wang MZ
Acta Radiol; 2020 Sep; 61(9):1221-1227. PubMed ID: 31902220
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Cervical Cancer With Parametrial Invasion on Whole-Tumor Dynamic Contrast-Enhanced Magnetic Resonance Imaging Combined With Whole-Lesion Texture Analysis Based on T2- Weighted Images.
Li XX; Lin TT; Liu B; Wei W
Front Bioeng Biotechnol; 2020; 8():590. PubMed ID: 32596230
[No Abstract] [Full Text] [Related]
6. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
7. Application of Dynamic Contrast-Enhanced MRI Parameters for Differentiating Squamous Cell Carcinoma and Malignant Lymphoma of the Oropharynx.
Park M; Kim J; Choi YS; Lee SK; Koh YW; Kim SH; Choi EC
AJR Am J Roentgenol; 2016 Feb; 206(2):401-7. PubMed ID: 26797371
[TBL] [Abstract][Full Text] [Related]
8. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
9. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
[TBL] [Abstract][Full Text] [Related]
10. Distinguishing T1-2 and T3a tumors of rectal cancer with texture analysis and functional MRI parameters.
Sun D; Wu X; Wang L; Li G; Huang J; Li Y
Diagn Interv Radiol; 2022 May; 28(3):200-207. PubMed ID: 35748201
[TBL] [Abstract][Full Text] [Related]
11. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
[TBL] [Abstract][Full Text] [Related]
12. A Whole-Tumor Histogram Analysis of Apparent Diffusion Coefficient Maps for Differentiating Thymic Carcinoma from Lymphoma.
Zhang W; Zhou Y; Xu XQ; Kong LY; Xu H; Yu TF; Shi HB; Feng Q
Korean J Radiol; 2018; 19(2):358-365. PubMed ID: 29520195
[TBL] [Abstract][Full Text] [Related]
13. Blood Oxygenation Level Dependent Magnetic Resonance Imaging (MRI), Dynamic Contrast Enhanced MRI, and Diffusion Weighted MRI for Benign and Malignant Breast Cancer Discrimination: A Preliminary Experience.
Fusco R; Granata V; Mattace Raso M; Vallone P; De Rosa AP; Siani C; Di Bonito M; Petrillo A; Sansone M
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34067721
[TBL] [Abstract][Full Text] [Related]
14. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
[TBL] [Abstract][Full Text] [Related]
16. Dynamic contrast-enhanced MRI in orbital lymphoproliferative disorders: Effects of region of interest selection methods on time efficiency, measurement reproducibility, and diagnostic ability.
Qian W; Xu XQ; Hu H; Su GY; Wu JF; Shi HB; Wu FY
J Magn Reson Imaging; 2018 May; 47(5):1298-1305. PubMed ID: 28922524
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.
Bathla G; Soni N; Endozo R; Ganeshan B
Neuroradiol J; 2019 Jun; 32(3):203-209. PubMed ID: 30789057
[TBL] [Abstract][Full Text] [Related]
18. Diffusion kurtosis imaging and dynamic contrast-enhanced MRI for the differentiation of parotid gland tumors.
Huang N; Chen Y; She D; Xing Z; Chen T; Cao D
Eur Radiol; 2022 Apr; 32(4):2748-2759. PubMed ID: 34642805
[TBL] [Abstract][Full Text] [Related]
19. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
20. Preoperative histogram parameters of dynamic contrast-enhanced MRI as a potential imaging biomarker for assessing the expression of Ki-67 in prostate cancer.
Zhang Y; Li Z; Gao C; Shen J; Chen M; Liu Y; Cao Z; Pang P; Cui F; Xu M
Cancer Med; 2021 Jul; 10(13):4240-4249. PubMed ID: 34117733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
